Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
- PMID: 27295554
- DOI: 10.1038/ncb3371
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Abstract
Tumour-associated macrophages (TAMs) largely express an alternatively activated (or M2) phenotype, which entails immunosuppressive and tumour-promoting capabilities. Reprogramming TAMs towards a classically activated (M1) phenotype may thwart tumour-associated immunosuppression and unleash anti-tumour immunity. Here we show that conditional deletion of the microRNA (miRNA)-processing enzyme DICER in macrophages prompts M1-like TAM programming, characterized by hyperactive IFN-γ/STAT1 signalling. This rewiring abated the immunosuppressive capacity of TAMs and fostered the recruitment of activated cytotoxic T lymphocytes (CTLs) to the tumours. CTL-derived IFN-γ exacerbated M1 polarization of Dicer1-deficient TAMs and inhibited tumour growth. Remarkably, DICER deficiency in TAMs negated the anti-tumoral effects of macrophage depletion by anti-CSF1R antibodies, and enabled complete tumour eradication by PD1 checkpoint blockade or CD40 agonistic antibodies. Finally, genetic rescue of Let-7 miRNA activity in Dicer1-deficient TAMs partly restored their M2-like phenotype and decreased tumour-infiltrating CTLs. These findings suggest that DICER/Let-7 activity opposes IFN-γ-induced, immunostimulatory M1-like TAM activation, with potential therapeutic implications.
Similar articles
-
Targeting Dicer reprograms tumor-associated macrophages to promote anti-tumoral immunity in colorectal cancer liver metastasis.J Nanobiotechnology. 2025 Jun 6;23(1):421. doi: 10.1186/s12951-025-03518-4. J Nanobiotechnology. 2025. PMID: 40481520 Free PMC article.
-
Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA level.Int J Cancer. 2014 Dec 15;135(12):2868-77. doi: 10.1002/ijc.28945. Epub 2014 May 14. Int J Cancer. 2014. PMID: 24789737
-
ILC1-derived IFN-γ regulates macrophage activation in colon cancer.Biol Direct. 2023 Sep 7;18(1):56. doi: 10.1186/s13062-023-00401-w. Biol Direct. 2023. PMID: 37679802 Free PMC article.
-
Diverse macrophages polarization in tumor microenvironment.Arch Pharm Res. 2016 Nov;39(11):1588-1596. doi: 10.1007/s12272-016-0820-y. Epub 2016 Aug 25. Arch Pharm Res. 2016. PMID: 27562774 Review.
-
Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.J Hematol Oncol. 2024 Jun 11;17(1):44. doi: 10.1186/s13045-024-01559-0. J Hematol Oncol. 2024. PMID: 38863020 Free PMC article. Review.
Cited by
-
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.J Clin Med. 2020 Jun 24;9(6):1973. doi: 10.3390/jcm9061973. J Clin Med. 2020. PMID: 32599760 Free PMC article.
-
Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.Neoplasia. 2020 Nov;22(11):606-616. doi: 10.1016/j.neo.2020.08.006. Epub 2020 Oct 8. Neoplasia. 2020. PMID: 33039895 Free PMC article.
-
MicroRNAs in Macrophages: Regulators of Activation and Function.J Immunol. 2023 Feb 15;210(4):359-368. doi: 10.4049/jimmunol.2200467. J Immunol. 2023. PMID: 36724439 Free PMC article. Review.
-
Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles.Cell Rep. 2019 Jun 4;27(10):3062-3080.e11. doi: 10.1016/j.celrep.2019.05.008. Cell Rep. 2019. PMID: 31167148 Free PMC article.
-
Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma.Oncogene. 2022 Jul;41(30):3791-3803. doi: 10.1038/s41388-022-02393-9. Epub 2022 Jun 28. Oncogene. 2022. PMID: 35764885
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous